The Australian Medicines
Terminology (AMT) v3 Beta
Feedback Summary Results
document summarises the
responses received from
stakeholders during the AMT v3
Beta feedback activities undertaken
during 2013.
The upcoming AMT v3 Preproduction
and Production release
data will be compliant with this
updated model.
Intending users are urged to
familiarise themselves with changes.
CLICK HERE to view the full results
document.The above article was sent to subscribers in Pharmacy Daily's issue from 19 Feb 14 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 19 Feb 14
BREAST Cancer Network Australia (BCNA) has welcomed a PBAC recommendation to subsidise the breast cancer drug Enhertu (trastuzumab deruxtecan) for HER2-low metastatic breast cancer on the PBS.
PHARMACY Connect (PC2024) has revealed that Olympian Peter Bol will be sharing his journey from adversity to athletic greatness at the conference in Sep in Sydney.
IN WESTERN Australia, Michael’s Chemist Group has started stocking therapeutic Nicotine Vaping Products (NVPs), pursuant to the Federal Government’s new vaping laws (PD 25 Mar).
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.